海外の治験の状況「1」での検索結果
11979件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
- ST-elevation Myocardial Infarction
- United Kingdom
- 2013-06-17
Authorised
- The comparison of the number of insulin-producing cells during and shortly after the honeymoon phase of type 1 diabetes
- Type 1 diabetes MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
- Netherlands
- 2017-11-13
Recruiting
- Multicenter Pheochromocytoma and Paraganglioma Evaluation
- Pheochromocytoma;Paraganglioma;Pheochromocytoma;Paraganglioma;Pheochromocytoma;Paraganglioma;Pheochromocytoma;Paraganglioma
- Germany
- 2017-11-02
Recruiting
- Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Spain
- 2017-10-29
Not recruiting
- Rehabilitative Trial With tDCS in Amyotrophic Lateral Sclerosis
- Amyotrophic Lateral Sclerosis
- Italy
- 2017-09-21
Recruiting
- Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1
- Tyrosinosis;Hepatorenal Tyrosinemia;Fumarylacetoacetase Deficiency;Fah Deficiency;Metabolic Disorders
- Egypt, Germany, India
- 2017-09-13
Authorised
- A Study to Assess the Long-term Safety of Rechon Insulin Human Soluble in Type 1 Diabetic Patients.
- Type 1 Diabetes MedDRA version: 20.0 Level: PT Classification code 10012601 Term: Diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Germany, Poland
- 2017-08-29
Recruiting
- INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
- Atherosclerosis;Cardiovascular Diseases;Atherosclerosis;Cardiovascular Diseases;Atherosclerosis;Cardiovascular Diseases;Atherosclerosis;Cardiovascular Diseases
- United Kingdom
- 2017-08-14
Authorised
- Fibrinogen (blood protein) supplementation in patients that have developed fibrinogen deficiency during surgery.
- The sequence of events culminating in Pseudomyxoma peritonei (PMP) is thought to involve growth of an appendiceal adenoma with distension of the appendix by mucus and mucinous tumour cells. The appendix eventually ruptures. Patients undergoing the PMP surgery develop a coagulopathy predominantly characterised by reduced levels of fibrinogen, resulting in reduced whole blood clot firmness. MedDRA version: 20.0 Level: PT Classification code 10037138 Term: Pseudomyxoma peritonei System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
- United Kingdom
- 2018-06-29
Recruiting
- Automated insulin delivery among pregnant women with type 1 diabetes
- Syndrome of infant of a diabetic mother Nutritional, Metabolic, Endocrine Type 1 diabetes mellitus
- United Kingdom
- 2018-04-10
Recruiting
- Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1
- SMA
- Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
- 2018-03-04
Recruiting
- A phase 1, partially blind, placebo-controlled, ascending single and multiple oral dose, safety, tolerability, pharmacokinetic and pharmacodynamic study in healthy subjects and osteoarthritis patients administered APPA-1
- Specialty: Musculoskeletal disorders, Primary sub-specialty: Non-inflammatory Joint Disorders; UKCRC code/ Disease: Musculoskeletal/ Arthrosis Musculoskeletal Diseases Arthrosis
- United Kingdom
- 2018-01-30
Not recruiting
- Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia
- Hypercholesterolemia
- Spain
- 2018-01-28
Not recruiting
- Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound
- Healthy
- Germany
- 2008-04-04
Not recruiting
- A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
- Melanoma;Sarcoma;Gastrointestinal Stromal Tumor (GIST);Head and Neck Cancer;Transitional Cell Carcinoma;Prostate Cancer;Ovarian Carcinoma;Esophageal Cancer;Breast Cancer;Melanoma;Sarcoma;Gastrointestinal Stromal Tumor (GIST);Head and Neck Cancer;Transitional Cell Carcinoma;Prostate Cancer;Ovarian Carcinoma;Esophageal Cancer;Breast Cancer;Melanoma;Sarcoma;Gastrointestinal Stromal Tumor (GIST);Head and Neck Cancer;Transitional Cell Carcinoma;Prostate Cancer;Ovarian Carcinoma;Esophageal Cancer;Breast Cancer;Melanoma;Sarcoma;Gastrointestinal Stromal Tumor (GIST);Head and Neck Cancer;Transitional Cell Carcinoma;Prostate Cancer;Ovarian Carcinoma;Esophageal Cancer;Breast Cancer
- Germany
- 2008-02-04
Not recruiting
- Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis
- Atopic Dermatitis
- Germany
- 2008-01-24
Authorised
- Long term subcutaneous tinzaparin compared with tinzaparin and oral anticoagulants in the treatment of acute pulmonary embolism. A multicentre, prospective, randomised, open, parallel group clinical trial.
- Patients with clinical suspicion of Pulmonar Thromboembolism confirmed according to the PIOPED criteria. MedDRA version: 4.0 Level: PT Classification code 10037377
- Spain
- 2005-12-01
Not Recruiting
- A clinical trial to see the effect of SKI-606 in Philadelphia Chromosome Positive Leukemias
- Leukemia, Myeloid, Philadelphia Positive
- Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Finland, Germany, Hong Kong, Hungary, India, Italy, Mexico, Netherlands, Peru, Republic of Korea, Russian Federation, Singapore, South Africa, Spain, Sweden, Taiwan, United Kingdom, United States of America
- 2009-09-01
Not recruiting
- Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins
- Type 2 Diabetes
- France
- 2009-08-05
Not Recruiting
- FOCUS 3 A study to determine the feasibility of molecular selection of therapy using KRAS, BRAF and topo-1 in patients with metastatic or locally advanced colorectal cancer. - FOCUS 3-Feasibility of molecular selection using KRAS, BRAF and topo-1
- metastatic or locally advanced colorectal cancer MedDRA version: 9.1 Level: LLT Classification code 10052362 Term: metastatic colorectal cancer
- United Kingdom
- 2009-05-15
